×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
|
Dashboard
Analyses
Exchange
Gaps
←
Home
/
Wiki
/
Therapeutic: Section 147 Neuroimmune Interface and Glial-Neuronal Crossta
therapeutic
1,590 words
KG: ent-dise-bfd8f32d
Contents
Section 147 Neuroimmune Interface and Glial-Neuronal Crosstalk Therapy in CBS/PSP
💊
Therapeutic Info
Name
ent-dise-bfd8f32d
No AI portrait yet
Generate portrait ✦
Knowledge Graph
Related Hypotheses (30)
Programmable Neuronal Circuit Repair via Epigenetic CRISPR
Score: 0.60
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
SASP-Mediated Complement Cascade Amplification
Score: 0.91
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.85
Purinergic Signaling Polarization Control
Score: 0.71
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
Context-Dependent CRISPR Activation in Specific Neuronal Sub
Score: 0.68
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.64
The Glial Ketone Metabolic Shunt Hypothesis
Score: 0.61
TREM2-mediated microglial tau clearance enhancement
Score: 0.59
Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption
Score: 0.47
Microbial Inflammasome Priming Prevention
Score: 0.65
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Vagal Afferent Microbial Signal Modulation
Score: 0.62
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.56
Aquaporin-4 Polarization Rescue
Score: 0.73
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.78
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66
Vocal Cord Neuroplasticity Stimulation
Score: 0.52
TREM2-Dependent Microglial Senescence Transition
Score: 0.95
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.92
CYP46A1 Overexpression Gene Therapy
Score: 0.92
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
Show 25 more
Related Analyses (27)
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Show 22 more
Related Experiments (26)
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40
tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
NPH Glymphatic System Interaction Experiment
clinical · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.40
Show 21 more
See Also (15)
Neural Circuit Disruption in Neurodegeneration
mechanism · Pages share 8 hypotheses
Microglial Priming Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Antibody Therapy in Neurodegeneration
mechanism · Pages share 7 hypotheses
Dystrophic Neurites in Neurodegeneration
mechanism · Pages share 7 hypotheses
gp130/IL-6 Family Cytokine Signaling in Neurodegenerati
mechanism · Pages share 7 hypotheses
Lipid Metabolism Dysregulation in Neurodegeneration
mechanism · Pages share 7 hypotheses
Convergent Pathways in Neurodegeneration
mechanism · Pages share 7 hypotheses
Axon Guidance Pathways in Neurodegeneration
mechanism · Pages share 7 hypotheses
COVID-19 Neurodegeneration Mechanism
mechanism · Pages share 7 hypotheses
Down Syndrome Neurodegeneration Pathway
mechanism · Pages share 7 hypotheses
A Phase 3, Randomised, Double-blinded, Placebo-controll
clinical · Pages share 7 hypotheses
Galectin-3 Mechanism in Neurodegeneration
mechanism · Pages share 7 hypotheses
HMGB1 Signaling in Neurodegeneration
mechanism · Pages share 7 hypotheses
IL-1 Signaling Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Show 10 more
Knowledge Graph (2 edges)
therapeutics-cytoskeletal-dynamics-tubulin-targeting-cbs-psp
describes
ent-dise-bfd8f32d
therapeutics-section-156-pet-therapy-animal-assisted-interventions-cbs-psp
describes
ent-dise-bfd8f32d
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)